MBF2 Is a Tissue- and Stage-Specific Coactivator That Is Regulated at the Step of Nuclear Transport in the Silkworm Bombyx mori  by Liu, Qing-Xin et al.
e
M
p
t
m
p
f
l
i
s
Developmental Biology 225, 437–446 (2000)
doi:10.1006/dbio.2000.9836, available online at http://www.idealibrary.com onMBF2 Is a Tissue- and Stage-Specific Coactivator
That Is Regulated at the Step of Nuclear Transport
in the Silkworm Bombyx mori
Qing-Xin Liu, Hitoshi Ueda, and Susumu Hirose1
Department of Developmental Genetics, National Institute of Genetics, and Department of
Genetics, Graduate University for Advanced Studies, Mishima, Shizuoka-ken 411-8540, Japan
Coactivators MBF1 and MBF2 mediate BmFTZ-F1-dependent transcriptional activation in vitro by interconnecting
BmFTZ-F1, TATA binding protein TBP, and TFIIA. Here, we analyzed temporal and spatial expression patterns of MBF2
during embryonic and larval development of the silkworm Bombyx mori. MBF2 was detected in unfertilized eggs and
mbryos until stage 26. In stage 22 embryos, MBF1, MBF2, and BmFTZ-F1 colocalize in neural cells. During the larval stage,
BF2 was not expressed in the fat body and trachea. In the silk gland, MBF2 mRNA was constitutively expressed, but MBF2
rotein appeared in the period between the second day and the molting D3 stage in both the third and the fourth instars and
hen disappeared. MBF2 was also detected on the second and third days of the fifth instar. Immunostaining during the fourth
olt showed that MBF1, MBF2, and BmFTZ-F1 localize in the nucleus only at the D3 stage, while the two cofactors are
resent in the cytoplasm at other stages. Immunoprecipitation experiments suggested that MBF1, MBF2, and BmFTZ-F1
orm a complex at the D3 stage. Transient expression of these factors in Schneider cell line 2 revealed that MBF1 and MBF2
ocalize to the nucleus and enhance BmFTZ-F1-dependent transcription only when all three factors are present. These data
llustrate the functional regulation of MBF1 and MBF2 at the step of nuclear transport and implicate MBF2 in tissue- and
tage-specific transcription. © 2000 Academic Press
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oINTRODUCTION
Development of multicellular organisms is accomplished
through concerted gene expression under precise temporal
and spatial control. Many cis-regulatory elements on DNA
and regulatory proteins that bind to them in a sequence-
specific fashion are involved in the control (Johnson and
McKnight, 1989; Mitchell and Tjian, 1989). Subsequent
studies have shown that non-DNA-binding factors termed
coactivators and mediators play an important role by inter-
connecting the DNA-binding regulators and basal transcrip-
tion machinery (Lewin, 1990; Roeder, 1991; Janknecht and
Hunter, 1996; Kornberg, 1996; Torchia et al., 1998; King-
ston, 1999). Proper combination of the cis elements, DNA-
binding regulators, and coactivators appears to be critical
for temporal and spatial control (Mannervik et al., 1999).
FTZ-F1 has been identified as a DNA-binding regulator in
1 To whom correspondence should be addressed. Fax: 81 559 81
6776. E-mail: shirose@lab.nig.ac.jp.
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All rights of reproduction in any form reserved.rosophila melanogaster (Ueda et al., 1990). Two isoforms,
a and bFTZ-F1, are transcribed from the ftz-f1 locus (La-
orgna et al., 1991, 1993). aFTZ-F1 governs expression of
fushi tarazu in blastoderm embryos (Ueda et al., 1990; H.U.
and S.H., unpublished observation). bFTZ-F1 and its Bom-
yx mori counterpart BmFTZ-F1 are expressed during late
mbryogenesis, each ecdysis, and metamorphosis after the
ulse of ecdysone (Ueda and Hirose, 1990; Sun et al., 1994;
eda et al., 1995).
Expression of BmFTZ-F1 can be induced in cultured silk
lands by exposure to and subsequent withdrawal of ecdy-
teroid (Sun et al., 1994). bFTZ-F1 is required for induction
f EDG84A and three late prepupal genes (Woodard et al.,
994; Murata et al., 1996). Furthermore, ectopic expression
f FTZ-F1 during the larval stage, in which endogenous
bFTZ-F1 is absent, causes lethal damage in the develop-
ment (Ueda et al., 1995). These data suggest that temporally
restricted expression of bFTZ-F1 is critical for larval devel-
opment and metamorphosis.Li et al. (1994) have shown that BmFTZ-F1 can activate
437
b
r
t
t
v
1
s
m
M
h
p
a
(
p
l
e
M
a
w
p
n
d
B
p
1
i
s
d
d
f
l
p
v
(
T
D
A
T
s
b
f
t
M
m
w
E
438 Liu, Ueda, and Hirosetranscription by binding to the FTZ-F1 recognition site in a
posterior silk gland extract. This transcriptional activation
requires two additional factors, MBF1 and MBF2, that do
not directly bind to DNA (Li et al., 1994). MBF1 is a
ridging molecule that connects BmFTZ-F1 and TBP and
ecruits a positive cofactor, MBF2, to a promoter carrying
he FTZ-F1 binding site. MBF2 activates transcription
hrough its contact with TFIIA. This allows selective acti-
ation in a FTZ-F1 binding site-dependent manner (Li et al.,
997; Takemaru et al., 1997). So far, we found MBF2
equence in only three Lepidopteran species, B. mori, B.
andarina, and Samia cynthia (Liu et al., 1998), while
BF1 sequence is conserved across species from yeast to
uman (Takemaru et al., 1997).
The silkworm B. mori has an advantage for study of the
rocess of ecdysis because precisely staged samples are
vailable according to morphological changes of the spiracle
Kiguchi and Agui, 1981). This study describes expression
atterns of MBF2 mRNA and protein during embryonic and
arval development of B. mori. We found tissue-specific
xpression of MBF2 mRNA and stage-specific expression of
BF2 protein. At the fourth-instar molting stage D3, MBF1
nd MBF2 translocate to the nucleus and form a complex
ith BmFTZ-F1, while both cofactors reside in the cyto-
lasm at other stages. These two cofactors localize in the
ucleus and activate transcription from a BmFTZ-F1-
ependent promoter when simultaneously expressed with
mFTZ-F1 in Schneider cell line 2 (S2). Together with the
reviously established function of MBF2 in vitro (Li et al.,
997), these data suggest that MBF2 plays an important role
n the development of the silkworm as a tissue-specific and
tage-specific coactivator.
MATERIALS AND METHODS
Silkworm
A hybrid strain Shogetsu 3 Shunrei was used for analysis of
evelopmental expression patterns. Silkworms were raised at 28°C
uring the first and second instars, at 26°C during the third and
ourth instars, and at 25°C during the fifth instar on mulberry
eaves.
Determination of Developmental Stages
We sampled the developing eggs at 24-h intervals and staged
them according to Takami and Kitazawa (1960). Morphological
changes of the spiracle were used for determination of developmen-
tal stages during the larval molt (Kiguchi and Agui, 1981) as
follows: stage A, no distinct feature around the spiracle; stage B,
appearance of a dim spot on the dorsal side of the spiracle; stage C1,
the spot becomes a triangular, semitransparent area with a clear
border; stage C2, the same feature appears on the ventral side of the
spiracle; stages D1–D2, both transparent areas fuse (D1) and form
an oval ring (D2); stage D3, the new cuticle of the peritreme is
deposited as a white ring within the oval region; stage E1, the new
white peritreme begins to melanize; stage E2, the new sieve plate
region gradually turns dark; and stage F, new fifth-instar spiracle s
Copyright © 2000 by Academic Press. All rightappears after ecdysis. During the feeding stage, larvae were staged
by days elapsed since the last ecdysis. Roman and Arabic numerals
represent larval instar and day(s) after the last ecdysis (e.g., IV-1
means fourth instar first day).
RNA Extraction
Posterior or middle silk glands were excised from the silkworms
at various stages, washed with 13 SSC (150 mM NaCl and 15 mM
Na citrate), frozen in liquid nitrogen, and stored at 280°C. Frozen
silk glands were crushed into fine powder in a mortar under liquid
nitrogen before homogenization in 50 mM Tris–HCl (pH 7.5), 100
mM NaCl, 1 mM EDTA, 0.1% Sarkosyl, 2% SDS, and 1 mg/ml
roteinase K. Samples were extracted three times with an equal
olume of phenol/chloroform (1/1) saturated with 50 mM Tris–HCl
pH 7.5), precipitated with ethanol, and dissolved in 20 mM
ris–HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, and 0.5% SDS.
NA was eliminated by precipitating RNA twice with 2 M LiCl.
fter ethanol precipitation, the RNA was dissolved in 20 mM
ris–HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, and 0.1% SDS, and
tored at 220°C after addition of 2 volumes of ethanol (Okamoto et
al., 1982).
Northern Hybridization
Ten micrograms of total cellular RNA were used for Northern
analysis. Northern hybridization was performed at 60°C for 16 h in
53 Denhardt’s solution, 0.5% SDS, 10 mg/ml sonicated salmon
sperm DNA, and either MBF1, MBF2, or BmFTZ-F1 cDNA probe
which had been labeled with 32P by random priming. The mem-
ranes were washed twice with 23 SSC containing 1% SDS at 60°C
or 30 min and once with 0.23 SSC at room temperature.
MBF2 Antibody Production
A 207-bp cDNA fragment encoding amino acids 24–92 of MBF2
was subcloned into pGEX-2T vector (Pharmacia) and transformed
into Escherichia coli BL21 (DE3) cells. The induced GST fusion
protein was purified by glutathione–Sepharose 4B (Pharmacia)
chromatography and used to generate a polyclonal antibody in
rabbit. Only the 22-kDa MBF2 protein was detected when a
Western blot of total protein from silk glands of second day
fifth-instar larvae was probed with the antibody. The protein band
was competed out in the presence of the GST fusion protein used
as the antigen (data not shown). Rabbit polyclonal antibodies
against BmFTZ-F1 and MBF1 were gifts from G.-C. Sun and Marek
Jindra, respectively.
Western Blot Analyses
Embryos or posterior or middle silk glands were dissected in
phosphate-buffered saline (PBS) and samples were homogenized in
a loading buffer containing 2% SDS but lacking tracking dyes. After
cellular debris was removed by centrifugation, protein concentra-
tion was measured according to the method of Bradford (1976).
Samples containing 20 mg of protein were boiled for 10 min and
hen resolved on polyacrylamide/SDS gels (12.5% for MBF2 and
BF1, 8% for BmFTZ-F1). The proteins were transferred to PVDF
embranes (Boehringer Mannheim). The membranes were blocked
ith TBST [50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1 mM
DTA, and 0.1% Tween 20] containing 5% skim milk and 2% goat
erum for 2 h and then incubated with anti-MBF1, anti-MBF2, or
s of reproduction in any form reserved.
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439Tissue- and Stage-Specific Coactivator MBF2anti-BmFTZ-F1 antibody for 2 h at room temperature. After being
washed with TBST, the membranes were incubated with a horse-
radish peroxidase-conjugated goat anti-rabbit IgG antibody
(1:10,000) for 2 h and washed again. The bound antibody was
detected using the Super Signal CL-HRP substrate system (Pierce,
U.S.A.).
Tissue Staining
Whole embryos or silk glands were dissected in PBS and fixed in
25 mM Pipes–KOH, (pH 7.0), 0.5 mM EDTA, 0.25 mM MgSO4, 4%
formaldehyde for 60 min on ice, then permeabilized for 60 min at
room temperature in PBS containing 0.5% NP-40, and blocked for
30 min in PBS containing 0.1% BSA and 5% goat serum. Treatment
with a primary antibody was carried out for 90 min, followed by
incubation with a secondary antibody (anti-rabbit IgG-Cy3) for 90
min, both at room temperature. For staining of embryos, FITC–
anti-HRP was also added during the second incubation. Finally, the
samples were stained with DAPI for 30 min at room temperature.
FIG. 1. Western blot analyses of MBF1, MBF2, and BmFTZ-F1 in
. mori embryos. E0 is the unfertilized egg. E1–E30 are stages
ccording to Takami and Kitazawa (1960).
FIG. 2. Expression of BmFTZ-F1, MBF1, and MBF2 in the embryo
antibody which is known to stain neural cells. (G–I) Stained wit
Merged images of D and G, E and H, and F and I, respectively.
Copyright © 2000 by Academic Press. All rightImmunoprecipitation
For immunoprecipitation, 20 ml of IgG-conjugated Dyna beads
Dynal Oslo, Norway) containing 2 mg of IgG were incubated at 4°C
or 2 h with 40 ml of a primary antibody or the corresponding
preimmune serum and then washed with PBS. Silk gland extracts
were prepared as described (Ueda and Hirose, 1990), and a 60-ml
portion of the extract was added to the antibody-loaded beads. After
incubation at 4°C for 2 h, the beads were washed with PBS
containing 0.1% NP-40. Bound proteins were eluted from the beads
with an SDS loading buffer, resolved by SDS–PAGE, and analyzed
on a Western blot.
Transfections and Luciferase Assays
A reporter plasmid (pERREx3-tk-luc) has been constructed by
inserting three copies of an oligonucleotide containing the FTZ-F1
binding site into a vector carrying the herpesvirus thymidine
kinase gene (tk) promoter and the firefly luciferase gene (Fig. 7A).
pAc-Bmftz-f1, pAc-HA-mbf1, and pAc-Flag-mbf2 were constructed
by inserting the BmFTZ-F1, HA-tagged MBF1, or Flag-tagged MBF2
open reading frame into pPAc (Krasnow et al., 1989).
S2 cells (Schneider, 1972) were grown as described by Di Nocera
nd Dawid (1983) except that the growth medium contained 10%
etal bovine serum(heat inactivated at 56°C for 1 h). Cells were
assaged every 3 days and maintained at a density of 1 3 106 to 8 3
106 cells/ml in 6-cm tissue culture plates. For transfections, a late
log culture(6 3 106 cells/ml) was diluted with growth medium to
3 106 cells/ml and 1-ml (for immunostaining) or 2-ml (for
uciferase assays) aliquots were plated onto six-well tissue culture
lates. After 24 h at 25°C, the cells were transfected by using
ellFECTIN (Life Technologies, Inc., Rockville, MD). For immu-
ostaining, 1 mg of plasmids and 4 ml of the CellFECTIN reagent
ere used. For luciferase assays, 100 ng of pERREx3-tk-luc, 2 ng of
eference DNA (pRL-Act), and combinations of 900 ng each of
Ac-Bmftz-f1, pAc-HA-mbf1, and pAc-Flag-mbf2 were mixed and
ge 22. (A–C) Stained with DAPI. (D–F) Stained with an FITC–HRP
tibodies against BmFTZ-F1, MBF1, and MBF2, respectively. (J–L)at sta
h ans of reproduction in any form reserved.
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440 Liu, Ueda, and Hirosecombined with 8 ml of the CellFECTIN reagent. When any effector
lasmid was omitted from the mixture, it was replaced with pPAc.
fter 3 h incubation with transfection mixtures, the mixtures were
emoved and cells were added with 2 ml of the growth medium and
ncubated at 25°C for 48 h. After removal of the medium, each
late was supplemented with 500 ml passive lysis buffer (Promega;
dual luciferase system) and rocked at room temperature for 15 min.
Cell lysates were transferred into 1.5-ml Eppendorf tubes and
centrifuged for 30 s at 15K rpm. Luciferase activity (firefly or
Renilla) in the supernatant was determined according to the
manufacturer’s instructions(Promega) using a luminometer.
For immunostaining, S2 cells were grown on glass coverslips in
the growth medium. Cells were transfected with expression plas-
mids by using the CellFECTIN method as described above. After
transfection, cells were fixed with 4% formaldehyde in PBS for 10
min at room temperature and blocked for 30 min in PBS containing
0.1% BSA and 5% goat serum. Treatment with a primary antibody
[anti-HA monoclonal antibody 12CA5 (Roche Diagnostics, Mann-
heim, Germany), anti-Flag monoclonal antibody M2 (Kodak, New
Haven, CT), anti-MBF1, anti-MBF2, or anti-BmFTZ-F1 antibody]
was carried out for 1 h, followed by incubation with a secondary
antibody(anti-mouse IgG-Cy3 or anti-rabbit Alexa 488) for 30 min,
both at room temperature. Finally, the samples were mounted
using a mounting medium containing DAPI.
RESULTS
Expression Pattern of MBF2 during Embryonic
Stage
Development of the B. mori embryo is divided into 30
stages from egg laying to hatching (Takami and Kitazawa,
1960). We collected samples from 11 stages and analyzed
expression of MBF1, MBF2, and BmFTZ-F1 by Western
blotting. As shown in Fig. 1, MBF2 was present in unfertil-
ized eggs and in embryos until stage 26, but it disappeared
at stage 30. MBF1 was detected at all stages, although its
amounts were low in stages 5, 7, and 30. BmFTZ-F1
appeared only at the period between stages 16 and 26.
We used stage 22 embryos, in which MBF1, MBF2, and
BmFTZ-F1 were simultaneously expressed, to see localiza-
tion of these three factors by whole-mount staining with
the antibody (Fig. 2). MBF1, MBF2, and BmFTZ-F1 were
detected in the FITC–anti-HRP-positive cells, suggesting
that all three factors are coexpressed in neural cells of the
embryos. Such staining was not obtained when we used the
corresponding preimmune sera and it was competed out
with the recombinant proteins used for production of the
antibodies (data not shown). Markedly similar staining
patterns of MBF1, MBF2, and BmFTZ-F1 in the embryonic
neural cells are in good agreement with the conclusion of
our in vitro studies that MBF1 and MBF2 mediate BmFTZ-
F1-dependent transcriptional activation (Li et al., 1994,
1997). However, we were unable to judge their subcellular
localization unambiguously in these whole-mount prepara-
tions.
Copyright © 2000 by Academic Press. All rightExpression Pattern of MBF2 during Larval Stage
We prepared samples of total RNA from posterior silk
glands of feeding and molting stages at short intervals after
the time of head capsule slippage and according to the
timetable of spiracle-index stage (Kiguchi and Agui, 1981)
and analyzed 10-mg portions of RNA by Northern blotting.
s shown in Fig. 3A, 1.6- and 0.6-kb MBF2 mRNAs were
FIG. 3. Expression of MBF2, MBF1, and BmFTZ-F1 mRNA and
protein in the posterior silk gland during larval stage. (A) Total
RNA samples were analyzed by Northern blotting using MBF2,
BmFTZ-F1, or MBF1 cDNA as a probe. (B) Western blot analysis
using the antibodies against MBF1, MBF2, or BmFTZ-F1. III, IV, and
V represent larval instar. For the staging within each instar, see
Materials and Methods.
s of reproduction in any form reserved.
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441Tissue- and Stage-Specific Coactivator MBF2present at all stages from the third molting E2 stage to the
first day of the fifth instar. MBF1 mRNAs (1.6 and 1 kb)
were also expressed throughout the larval stages. As re-
ported before (Sun et al., 1994), expression of BmFTZ-F1
RNA was temporally regulated. It was detected at the
eriods from the third molting E2 stage to the second day of
he fourth instar and from the fourth molting D3 stage to
he second day of the fifth instar. Essentially, the same
esults were obtained using middle silk glands (data not
hown). We were unable to detect MBF2 mRNA in samples
rom the fat body and trachea (data not shown), indicating
issue-specific expression of MBF2.
Expression of MBF1, MBF2, and BmFTZ-F1 proteins in
osterior silk glands was examined on Western blots. As
hown in Fig. 3B, MBF2 protein appeared during the period
rom the second day to the molting D3 stage and then
isappeared in the period from the molting E1 stage to F
tage in both the third and the fourth instars. MBF2 was
gain detected on days 2 and 3 of the fifth instar. These
esults suggest a regulation of the expression of MBF2 at the
evel(s) of translation and/or protein stability. MBF1 protein
as expressed throughout the larval stages. BmFTZ-F1
rotein was detected at periods from the third molting D3
tage to the third day of the fourth instar and also from the
ourth molting D3 stage to the second day of the fifth instar,
onsistent with the mRNA profile. Essentially, the same
esults were obtained using middle silk glands (data not
hown). The developmental expression patterns of MBF1,
BF2, and BmFTZ-F1 during the larval stage are summa-
ized in Table 1.
We also carried out Western analyses of proteins from the
at body and tracheae. No band was detected when the blots
ere probed with the anti-MBF2 antibody, while the anti-
BF1 antibody gave a clear MBF1 band (data not shown).
TABLE 1
Summary of the Expression and Subcellular Localization of BmFT
Stage IV1 IV2 IVA IVC1 IVC2
MBF2
mRNA 1 1 1 1 1
Protein 2 1 1 1 1
Localization 2 C C C C
BmFTZ-F1
mRNA 1 1 2 2 2
Protein 1 1 2 2 2
Localization NT NT 2 2 2
MBF1
mRNA 1 1 1 1 1
Protein 1 1 1 1 1
Localization NT NT NT C C
Note. 1, present; 2, absent; C, cytoplasm; N, nucleus; NT, nothese results are in good agreement with those of Northern s
Copyright © 2000 by Academic Press. All rightybridization and indicate that MBF2 is not expressed in
hese tissues.
To determine the subcellular localization of MBF1,
BF2, and BmFTZ-F1 in the posterior silk gland, we
erformed tissue staining using the antibodies against
hese proteins. The silk gland cells contain large ramified
uclei and are highly polyploid. At the fourth molting A
tage or on day 2 of the fifth instar, staining patterns with
nti-MBF2 antibody were complementary to those with
API (Fig. 4A, the second or fourth row). The same
taining patterns were obtained in other MBF2-positive
tages thus far tested, except that the antibody staining
oincided with the DAPI staining at the fourth molting
3 stage (Fig. 4A, the third row). These results show that
BF2 resides in the nucleus only at the fourth molting
3 stage, while it is present in the cytoplasm at all other
tages (Table 1). Serving as a control for the specificity of
he staining is the day 1 fourth-instar silk gland, showing
o immunoreactivity in either Western blot or tissue
taining (Figs. 3B and 4A, the first row). MBF1 was also
etected in the nucleus only at the fourth molting D3
tage (Fig. 4B, the second row) but at all other times, it
ppeared in the cytoplasm (Fig. 4B, the first and the third
ows, and Table 1). BmFTZ-F1 was found in the nucleus
henever it was expressed (Fig. 4C, the second and the
hird rows, and Table 1), and no BmFTZ-F1 was detect-
ble by tissue staining at the fourth molting C1 stage
hen the factor is not expressed (Fig. 4C, the first row).
taining of the middle silk glands gave essentially the
ame results (data not shown). These patterns were not
bserved with preimmune sera and disappeared upon
ompetition with the corresponding recombinant pro-
eins (data not shown).
Collectively, these results indicate tissue-specific and
, MBF1, and MBF2 during Larval Stages
D1 IVD2 IVD3 IVE1 IVE2 V1 V2
1 1 1 1 1 1 1
1 1 1 2 2 2 1
C C N 2 2 2 C
2 2 1 1 1 1 1
2 2 1 1 1 1 1
2 2 N N N NT NT
1 1 1 1 1 1 1
1 1 1 1 1 1 1
C C N C C C NT
d.Z-F1
IV
testetage-specific expression of MBF2. They also suggest that
s of reproduction in any form reserved.
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Copyright © 2000 by Academic Press. All rightthe coactivator functions of MBF1 and MBF2 are regulated
at the step of nuclear transport.
MBF2 Forms a Complex with MBF1 and BmFTZ-F1
in Silk Gland Nuclei at the Fourth Molting D3
Stage
In vitro studies have shown that BmFTZ-F1, MBF1, and
MBF2 form a complex through protein–protein interactions
between BmFTZ-F1 and MBF1 and between MBF1 and
MBF2 (Li et al., 1994). To test whether these proteins also
interact in vivo, we carried out coimmunoprecipitation
experiments using a posterior silk gland extract of the
fourth molting D3 stage, when BmFTZ-F1, MBF1, and
MBF2 are all present in the nucleus. The immunoprecipi-
tation was performed using the antibody against BmFTZ-
F1, MBF1, or MBF2, and then the precipitated proteins were
detected by Western blotting. When immunoprecipitated
with either anti-BmFTZ-F1 or anti-MBF1 antibody, MBF2
was coimmunoprecipitated (Fig. 5A). Similarly, MBF1 was
coimmunoprecipitated with either anti-BmFTZ-F1 or anti-
MBF2 antibody (Fig. 5B). Because MBF2 does not directly
interact with BmFTZ-F1 (Li et al., 1994), coimmunoprecipi-
tation of MBF2 with the anti-BmFTZ-F1 antibody is most
likely achieved through a BmFTZ-F1–MBF1–MBF2 ternary
complex. In the molting D1 stage, when both MBF1 and
MBF2 are present in the cytoplasm, MBF1 was precipitated
with the anti-MBF2 antibody, but consistent with the
absence of BmFTZ-F1 at this stage, not with the anti-
BmFTZ-F1 antibody (Fig. 5C). In the molting E2 stage,
MBF1 resides in the cytoplasm, MBF2 is absent, and
BmFTZ-F1 is present in the nucleus (Table 1). As a negative
control, MBF1 was not coimmunoprecipitated with either
anti-BmFTZ-F1 or anti-MBF2 antibody at this stage (Fig.
5D). These results suggest the presence of an MBF1–MBF2
complex in the cytoplasm at the molting D1 stage and a
BmFTZ-F1–MBF1–MBF2 complex in the nucleus at the
molting D3 stage.
Simultaneous Expression of BmFTZ-F1, MBF1, and
MBF2 Is Necessary for Nuclear Localization of
MBF1 and MBF2
The data described above suggest that MBF1 and MBF2
localize to the nucleus and form the complex with
BmFTZ-F1 at the molting D3 stage. However, we were
unable to answer the question whether the nuclear local-
ization of MBF1 and MBF2 occurs within the same cells
that express BmFTZ-F1, because all three antibodies were
FIG. 4. Subcellular localization of MBF2, MBF1, and BmFTZ-F1
in the posterior silk gland. Antibodies were applied as indicated.
Left shows staining with DAPI to indicate the positions of nuclei.
In (A) and (B), right shows the merged images of antibody and DAPI
staining.s of reproduction in any form reserved.
e
d
c
d
M
E
s
w
s
o
B
n
w
e
e
r
443Tissue- and Stage-Specific Coactivator MBF2raised in rabbits and hence, we could not immunostain two
proteins separately in the same preparation. To address the
issue, we expressed BmFTZ-F1, HA-tagged MBF1, and Flag-
tagged MBF2 in D. melanogaster S2 cells using actin 5C
promoter-driven construct (Fig. 7A). When untransfected S2
cells were stained with the antibody against BmFTZ-F1,
which also cross-reacts with FTZ-F1, or that against MBF2,
no signals were detectable (Figs 6A and 6C). Essentially the
same results were obtained when an anti-HA or an anti-Flag
monoclonal antibody was used (data not shown). In con-
trast, mainly cytoplasmic staining was detected using the
antibody against MBF1 (Fig. 6B). When a Western blot of
total proteins from S2 cells was probed with the same
antibody, we observed a single band of MBF1 (data not
shown). These results show that untransfected S2 cells
express Drosophila MBF1 but do not contain FTZ-F1 and
MBF2.
When HA-tagged MBF1 was expressed in S2 cells, it was
detected mainly in the cytoplasm using the anti-HA anti-
body (Fig. 6D) or the anti-MBF1 antibody (Fig. 6E). Upon
expression of Flag-tagged MBF2, we observed its perinuclear
but cytoplasmic staining with the anti-Flag (Fig. 6G) or with
the anti-MBF2 antibody (Fig. 6H). Note that the antibody
staining was excluded from the DAPI-stained nuclear area
(compare Figs. 6G and 6I and also compare 6H and 6I).
Western blot analysis of subcellular fractions confirmed the
FIG. 5. Coimmunoprecipitation of MBF1, MBF2, and BmFTZ-F1.
(A)–(D), IP indicates which antibody was used for immunoprecipit
protein on the Western blots. Lanes 1 contain input protein. Lanes
anti-MBF2.presence of MBF2 in the cytoplasm (data not shown).When-
Copyright © 2000 by Academic Press. All rightver BmFTZ-F1 was expressed in S2 cells, it was always
etected in the nucleus (Figs. 6J, 6M, 6S, and 6Y).
Simultaneous expression of MBF1 and MBF2 did not
hange their subcellular localization. Thus, HA-MBF1 was
etected mainly in the cytoplasm (Fig. 6O) and the anti-
BF2 antibody showed the perinuclear staining (Fig. 6P).
xpression of BmFTZ-F1 and MBF1 also did not alter the
ubcellular localization of MBF1 as revealed by staining
ith the anti-HA antibody (Fig. 6L). However, upon expres-
ion of BmFTZ-F1 and MBF2, we observed staining signals
f the anti-Flag antibody within the nucleus (Fig. 6R). When
mFTZ-F1, MBF1, and MBF2 were expressed simulta-
eously, both MBF1 (Fig. 6V) and MBF2 (Figs. 6U and 6X)
ere detected in the nucleus. Considering the expression of
ndogenous MBF1 in S2 cells, these results indicate that
xpression of all three factors within the same cells is
equired for nuclear localization of MBF1 and MBF2.
MBF1 and MBF2 Enhance BmFTZ-F1-Dependent
Transcription in Cultured Cells
In vitro studies have shown that MBF1 and MBF2 serve as
coactivators for BmFTZ-F1-dependent transcription (Li et
al. 1994, 1997). To examine the effect of MBF1 and MBF2 on
BmFTZ-F1-dependent transcription in a living cell, a re-
porter construct was cotransfected with the expression
erior silk gland extracts from the indicated stages were tested. In
in each lane, and WB indicates the antibody used for detection of
(A) and (B) are controls with the preimmune serum before raisingPost
ation
2 inplasmids of MBF1, MBF2, and/or BmFTZ-F1 into S2 cells
s of reproduction in any form reserved.
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Copyright © 2000 by Academic Press. All right(Fig. 7A). The reporter plasmid carries three tandemly
repeated FTZ-F1 binding sites, the herpesvirus tk gene
promoter, and a luciferase gene. Upon expression of
BmFTZ-F1 alone, we observed severalfold increase in the
luciferase activity (Fig. 7B). Expression of BmFTZ-F1 and
MBF1 did not change the results but expression of
BmFTZ-F1 and MBF2 enhanced the luciferase activity.
Further addition of MBF1 expression plasmid did not result
in further increase of the activity. In the absence of BmFTZ-
F1, expression of MBF1 and MBF2 did not increase the
luciferase activity. Considering the presence of endogenous
MBF1 in S2 cells (see above), these results demonstrate that
MBF1 and MBF2 enhance BmFTZ-F1-dependent transcrip-
tional activation. Cooperation of Drosophila MBF1 with
BmFTZ-F1 and MBF2 in both the nuclear localization and
the transcriptional activation is not surprising since even
the defect of yeast mbf1 disruption can be rescued by
expression of human, silkworm, or Drosophila MBF1
(Takemaru et al., 1997).
DISCUSSION
Regulation of the Expression of MBF2
In this study, we describe the expression pattern of MBF2
(Table 1). During the larval stage, MBF2 mRNA was con-
stitutively expressed, but MBF2 protein was detected only
at specific stages. These results suggest that the expression
of MBF2 protein is regulated posttranscriptionally. Li et al.
1994) have shown that poly(A)1 mRNA of MBF2 is present
n the silk gland at the fourth molting stage and the second
ay of the fifth instar but is barely detectable on the third
ay of the fourth instar and the fifth day of the fifth instar.
nterestingly, the poly(A)1 mRNA has been detected only in
hose stages at which MBF2 protein is expressed. When
otal RNA was used for Northern analyses, we were unable
o find such variation in the level of MBF2 mRNA (Fig. 3A).
he discrepancy can be explained if we assume a selective
oss of MBF2 mRNA with short poly(A) tail during oligo(dT)
hromatography. We surmise that translation of MBF2
RNA is regulated by the size of its poly(A) tail.
MBF2 was present until the molting D stage but disap-
eared rapidly at the E stage (Fig. 3B). This raises a possi-
ility that the disappearance of the factor is regulated by
cdysteroids. However, we were unable to detect any effect
f 20-hydroxyecdysone on the disappearance of MBF2 in
ultured posterior silk glands under conditions under which
xpression of BmFTZ-F1 mRNA was successfully induced.
Regulation at the Step of Nuclear Transport
The most interesting finding in the present study is the
dramatic change in the subcellular localization of MBF1
and MBF2 during development. The two cofactors are found
in the nucleus only in the molting D3 stage and in the
cytoplasm in other stages. Coimmunoprecipitation experi-FIG. 6. Nuclear localization of MBF1 and MBF2 upon ex-
pression of BmFTZ-F1 within the same cells. (A–C) Un-
transfected S2 cells were immunostained with the anti-
body indicated. (D–Z) S2 cells transfected with the indi-
cated expression plasmid(s) were stained with the antibodies
indicated and with DAPI. In (D)–(Z), each horizontal row showsments suggest that MBF1 and MBF2 are present as a
s of reproduction in any form reserved.
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445Tissue- and Stage-Specific Coactivator MBF2complex in the cytoplasm at the molting D1 stage and then
enter the nucleus and form a ternary complex with
BmFTZ-F1 at the molting stage D3. Transient expression of
these factors in S2 cells showed that simultaneous expres-
sion of BmFTZ-F1 is essential for the nuclear localization of
MBF1 and MBF2. It is possible that the ternary complex is
formed in the cytoplasm and transported into the nucleus
together with BmFTZ-F1. Alternatively, the MBF1–MBF2
complex may be constitutively excluded from the nucleus
through a nuclear export system but it may stay in the
nucleus once the ternary complex with BmFTZ-F1 is
formed. MBF1 contains a nuclear export signal (NES)-like
sequence in its C-terminal region, which is conserved
among eukaryotes. For example, amino acid residues 119–
130 of B. mori MBF1, LGKIERAIGIKL, and the correspond-
ing region of human MBF1, LGIERAIGLKL (Kabe et al.,
1999), are similar to the leucine-rich NES in HIV Rev
protein, LPPLERLTL, and protein kinase inhibitor,
LALKLAGLDI (Gerace, 1995). Whatever the mechanism
may be, our finding reveals a regulation of the action of
these coactivators at the step of nuclear transport.
Possible Role of MBF1 and MBF2 in the Silkworm
Tissue staining of embryos showed the colocalization of
BmFTZ-F1, MBF1, and MBF2 in neural cells, suggesting
that these transcription factors play a role in the embryonic
neural cells. During larval development, BmFTZ-F1, MBF1,
and MBF2 form a nuclear complex at the molting stage D3.
Transient expression of a reporter gene in S2 cells demon-
strated that MBF1 and MBF2 enhance BmFTZ-F1-
FIG. 7. Transcriptional activation by MBF1, MBF2, and BmFTZ
construct and expression plasmids. (B) Luciferase assays. Indic
(pERREx3-tk-luc) and a reference DNA (pRL-Act) into S2 cells. Luc
Renilla luciferase activity in each sample and the activity relative
are the averages (6SE) of six experiments.dependent transcription. These observations support our i
Copyright © 2000 by Academic Press. All rightodel that MBF1 and MBF2 serve as coactivators that
ediate BmFTZ-F1-dependent transcriptional activation
Li et al., 1997). However, BmFTZ-F1 expression only
egins from the D3 stage and culminates later at the E1 and
2 stages, when MBF2 has already disappeared and MBF1
esides in the cytoplasm (Figs. 3B and 4B). It is possible that
BF1 and MBF2 are required only to initiate expression of
utative BmFTZ-F1 target genes in D3 stage. The small
mount of BmFTZ-F1 in D3 stage may be enough to play
he role because MBF1 can significantly stabilize
mFTZ-F1 binding to DNA (Li et al., 1994; Takemaru et al.,
997). When present at high levels, BmFTZ-F1 no longer
equires the aid of MBF1 and MBF2 to maintain the expres-
ion of its target gene(s) and these cofactors may be ex-
luded from the system to turn off the expression rapidly
pon decline in the level of BmFTZ-F1. This may allow
mmediate turn on and off of the BmFTZ-F1-dependent
ene(s).
Why is FTZ-F1 function under precise temporal control?
TZ-F1 appears to regulate its target genes that should be
xpressed only within a limited time. For example, Dro-
ophila bFTZ-F1 governs stage-specific expression of the
EDG84A gene, which encodes a cuticle protein (Murata et
al., 1996). Manduca sexta FTZ-F1 is likely to regulate genes
acting in cuticle formation, including the dopadecarboxy-
lase gene, which is responsible for melanization of cuticle
(Hiruma et al., 1995). Insect cuticle consists of layers of
lm. Different layers contain different kinds of proteins.
hese proteins are expressed in a stage-specific manner and
re deposited systematically starting from epicuticle to
ndocuticle (Fristrom and Fristrom, 1993). Any disturbance
in cultured cells. (A) Schematic presentation of a reporter gene
expression plasmids were cotransfected with a reporter gene
se activity of the transfected cells was normalized to the reference
at of the sample without expression plasmid is shown. The results-F1
ated
ifera
to thn the order of protein deposition and melanization would
s of reproduction in any form reserved.
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446 Liu, Ueda, and Hirosebe detrimental to the cuticle formation. Indeed, Ueda et al.
(1995) observed disruption of the cuticle structure upon
ectopic expression of FTZ-F1 when endogenous bFTZ-F1 is
bsent. These observations support the notion that tempo-
ally restricted action of FTZ-F1 is critical for development.
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